# Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing

> **NIH NIH R44** · CURI BIO INC · 2021 · $69,068


## Key facts

- **NIH application ID:** 10355813
- **Project number:** 3R44HL149566-02S1
- **Recipient organization:** CURI BIO INC
- **Principal Investigator:** Nicholas Andrew Geisse
- **Activity code:** R44 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $69,068
- **Award type:** 3
- **Project period:** 2019-09-01 → 2022-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10355813

## Citation

> US National Institutes of Health, RePORTER application 10355813, Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing (3R44HL149566-02S1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10355813. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*